A new clinical trial at Kingston Health Sciences Centre could mark a turning point in how anxiety is treated in Canada. For the first time in Canada, researchers are studying the effects of micro-dose ...

Anxiety is a mental health condition millions of people around the world experience every day but not something that can necessarily be “seen”—until now. In a first-of-its-kind study, scientists at ...

Anxiety disorders affect more than 40 million adults in the U.S. each year, often interfering with sleep, relationships, work and day-to-day functioning. If you’ve been feeling on edge, overwhelmed or ...

Everyone experiences uncertainty at times, and that’s normal. But for some people, the need for absolute certainty can become overwhelming, taking over daily life. This is called the “intolerance of ...

Much as anxiety commandeers thought processes— jump-starting bouts of worry, demanding hypervigilance, imposing a sense of danger—it is a physiologic state, a response to detection of threat somewhere ...

With open enrollment now only two weeks away, and the federal government still on shutdown, health care stakeholders are growing anxious about the future of the Affordable Care Act enhanced premium ...

Anxiety and depression are common amongst college students, who face heightened pressure navigating young adulthood and academics at the same time. In the report, 11 percent of college students ...

David Toro was taken aback by the turnout at a climate change anxiety peer-support group. After all, his feelings of dread and powerlessness when he thought about climate change could be isolating.

Singer Doechii suffered a toe-curling calamity at her show after falling down a slide, after her heel got caught. She was singing her hit “Denial is a River” on Monday night at Madison Square Garden ...

The Fear and Greed Index has been stuck on "fear" for seven consecutive days, a state that — coupled with a bitcoin BTC $103,277.81 price constrained between between $103,000 and $115,000 for almost ...

Neuphoria Therapeutics’ lead candidate has failed to improve social anxiety symptoms in a late-stage trial, prompting the biotech to discontinue the program and launch a strategic review of its ...